ISPOR - PCN112 Cyclin Dependent Kinase (CDK) 4/6 Inhibitors and LUNG Inflammation: An Analysis of the United States FOOD and Drug Administrations' Adverse Event Reporting System

PCN112 Cyclin Dependent Kinase (CDK) 4/6 Inhibitors and LUNG Inflammation: An Analysis of the United States FOOD and Drug Administrations' Adverse Event Reporting System

Abstract

Authors

E. Borrelli C.G. McGladrigan

Full Text Cite This Article

Back to Volume 24, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now